![](/img/cover-not-exists.png)
160PCDK 4/6 inhibitors plus endocrine therapy in ER positive metastatic breast cancer (MBC): Systematic review and meta-analysis of randomized clinical trials
D’Avanzo, F, Saggia, C, Rossi, V, Siffredi, G, Barone Adesi, F, Gennari, AVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz100.011
Date:
May, 2019
File:
PDF, 74 KB
2019